Korro Bio, Inc. (KRRO) › Capital ExpendituresKorro Bio, Inc. (KRRO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $1.86M2018: $436.0K2019: $1.06M2020: $6.67M2021: $2.91M2022: $5.14M2023: $7.84M2024: $17.90M2025: $518.0K$518.0K2017Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$518.0K-97.1%2024$17.90M+128.5%2023$7.84M+52.6%2022$5.14M+76.3%2021$2.91M-56.3%2020$6.67M+527.0%2019$1.06M+144.0%2018$436.0K-76.6%2017$1.86M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share